期刊文献+

盐酸戊乙奎醚对慢性阻塞性肺病患者血流动力学和微循环的影响 被引量:7

The effect of penehyclidine hydrochloride on hemodynamics and microcirculation in patients with chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的观察盐酸戊乙奎醚对慢性阻塞性肺病(COPD)患者血流动力学和微循环的影响。方法 40例慢性阻塞性肺病患者均给予气管插管呼吸机辅助呼吸,随机分为两组,盐酸戊乙奎醚组(Ⅰ组):每12小时静注盐酸戊乙奎醚1mg;氨茶碱组(Ⅱ组):氨茶碱持续泵入0.6mg·kg-1.min-1。分别监测用药后2、4和6h的BP、HR和体温、血乳酸(ABL)含量、尿量。结果两组患者血流动力学差异无统计学意义。与Ⅱ组比较,用药后4、6hⅠ组体温升高(P<0.05),ABL含量降低(P<0.05),尿量增多(P<0.05)。结论盐酸戊乙奎醚应用于COPD患者不会引起血流动力学的改变;对微循环有明显改善。 Objective To observe the effect of penehyclidine hydrochloride on hemodynamics and microeirculation in patients with chronic obstructive pulmonary disease(COPD). Methods Forty patients with COPD were randomly divided into two groups. Group Ⅰ(penehyclidine hydrochloride) patients were injected 1 mg of penehyclidine hydrochloride evrey 12 hours; group Ⅱ (aminophylline) patients continuous infusioned aminophylline 0.6 mg·kg^-1·min^-1. Hemodynamic parameters (BP, HR, CVP) and microcirculation index (body temperature, lactic acid, urine) were measured in 2, 4 and 6 hour after tracheal intuhation. Results Hemodynamic parameters of the two groups were not significantly different. Patients in group I had significant higher body temperature, lower lactic acid and more urine than group Ⅱ (P〈0. 05). Conclusion Penehyclidine hydrochloride used in patients with COPD did not cause hemodynamic changes but could improve microcirculation significantly.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2010年第10期872-873,共2页 Journal of Clinical Anesthesiology
关键词 盐酸戊乙奎醚 慢性阻塞性肺病 血流动力学 微循环 Penehyelidine hydrochloride Chronic obstructive pulmonary disease Hemodynamics Mierocirculation
  • 相关文献

参考文献6

二级参考文献29

  • 1李靖,郑劲平,袁锦屏,杨灵,罗锭芬,安嘉颍,肖正伦,钟南山,钟维农,何为国,赵子文,曾军,林材元.口服八种细菌提取物对慢性支气管炎合并慢性阻塞性肺疾病急性加重的预防作用[J].中华结核和呼吸杂志,2004,27(9):631-633. 被引量:29
  • 2中华医学会呼吸病学分会,中华结核和呼吸杂志,1997年,20卷,199203页
  • 3Riees PJ.Tiotropium in the management of chronic obstructive pulmonary disease [J].Eur Respir J,2002,19 (2):205-206.
  • 4Donald PT,Christopher BC.The Role of long-Acting Bronchodilators int he management of stable COPD [J].Chest,2004,125 (1):249-259.
  • 5Donohue JF.Therapeutic responses in asthma and COPD [J].Chest,2004,126 (2):125s-127s.
  • 6Tachkin DP,Cooper CB.The role of long-acting bronchodilators in the management of stable COPD [J].Chest,2004,125 (1):249-259.
  • 7Cazzola M,Matera MG.Bronchodilators are the first-choice option for the treatment ofstable COPD [J].Chest,2004,125 (1):9-11.
  • 8Barnea PJ,Stochley RA.COPD:current therapeutic interventions and future approaches [J].Eur Respir J,2005,25 (6):1084-1106.
  • 9Barnes PJ. Muscarinic receptor subtypes in airways. Life Sci,1993,52:521-527.
  • 10Eglen RM,Reddy H,Watson N,et al. Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol Sci,1994,15:114-119.

共引文献5156

同被引文献41

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部